US Stock MarketDetailed Quotes

LPTX Leap Therapeutics

Watchlist
  • 2.4650
  • +0.2650+12.05%
Close Aug 9 16:00 ET
  • 2.4700
  • +0.0050+0.20%
Post 20:01 ET
94.32MMarket Cap-1972P/E (TTM)

Leap Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Leap Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.51

+84.26%
Analyst Rating

Strong Buy

Jul 31, 2024

Leap Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Leap Therapeutics Earnings Reports

  • Leap Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 06:53 ET

  • Leap Therapeutics | 10-K: FY2023 Annual Report

    Mar 18 06:54 ET

  • Leap Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 06:51 ET

  • Leap Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 06:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg